| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0.7B | $0.4B | $0.0B | $0.2B | $0.0B | $0.0B | $0.0B | $0.0B |
| Cost of Revenue | $0.8B | $0.4B | $0.0B | — | $0.0B | $0.0B | $0.0B | $0.0B |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | $0.0B | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $0.3B | $0.2B | $-0.0B | $-0.1B | $-0.0B | $-0.0B | $-0.0B | $-0.0B |
| Net Income | $0.5B | $0.3B | $-0.4B | $-0.0B | $-0.0B | $-0.0B | $-0.0B | $-0.0B |
| EPS (Basic) | $1.87 | $1.41 | $-3.14 | $-0.36 | — | — | — | — |
| EPS (Diluted) | $1.72 | $1.06 | — | $-0.36 | — | — | — | — |
| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $6.8B | $2.0B | $1.2B | $1.4B | $0.3B | $0.0B | $0.0B | $0.0B |
| Current Assets | $0.5B | $1.0B | $0.3B | $0.7B | $0.3B | $0.0B | $0.0B | $0.0B |
| Cash & Equivalents | $0.4B | $0.4B | $0.1B | $0.3B | $0.1B | $0.0B | $0.0B | $0.0B |
| Total Liabilities | — | — | — | $0.8B | $0.0B | $0.0B | $0.0B | $0.0B |
| Current Liabilities | $0.1B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| Stockholders' Equity | $4.1B | $1.6B | $0.4B | $0.7B | $0.3B | $0.0B | $0.0B | — |
| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $-0.7B | $-0.3B | $-0.2B | $-0.0B | $-0.0B | $-0.0B | $-0.0B | $-0.0B |
| Investing Cash Flow | $-3.2B | $0.0B | $-0.4B | $-0.9B | $-0.1B | $0.0B | $-0.0B | $-0.0B |
| Capital Expenditures | $0.3B | $0.0B | $0.0B | — | — | $0.0B | $0.0B | $0.0B |
| Financing Cash Flow | $4.0B | $0.6B | $0.4B | $1.0B | $0.2B | $0.0B | $0.0B | $0.0B |